Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

about

Analysis of urinary macrophage migration inhibitory factor in systemic lupus erythematosus

P2860

Q58588970-20050176-AC62-47DD-84CA-DE83D2234D89

P2860

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

Item

http://www.wikidata.org/entity/Q55401570

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

@en

Analysis of Serum Interleukin

@nl

type

Item

label

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

@en

Analysis of Serum Interleukin

@nl

prefLabel

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

@en

Analysis of Serum Interleukin

@nl

P1476

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

@en

P2093

Alberta Y Hoi

http://www.w3.org/2001/XMLSchema#string

Emily Lin

http://www.w3.org/2001/XMLSchema#string

Janet Chang

http://www.w3.org/2001/XMLSchema#string

Rachel Koelmeyer

http://www.w3.org/2001/XMLSchema#string

Rachel Mende

http://www.w3.org/2001/XMLSchema#string

P2860

Lupus nephritis: current update

MIF: Implications in the Pathoetiology of Systemic Lupus Erythematosus

A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosus

Efficacy and safety of belimumab in patients with active systemic lupus erythematosus: a randomised, placebo-controlled, phase 3 trial

Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus

Personalized Immunomonitoring Uncovers Molecular Networks that Stratify Lupus Patients

IL-18 cDNA vaccination protects mice from spontaneous lupus-like autoimmune disease.

Type I interferon in the pathogenesis of lupus.

Effect of hydroxychloroquine treatment on pro-inflammatory cytokines and disease activity in SLE patients: data from LUMINA (LXXV), a multiethnic US cohort

The classification of glomerulonephritis in systemic lupus erythematosus revisited.

P304

1250

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3389/FIMMU.2018.01250

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Tali Lang

Rangi Kandane-rathnayake

Eric F. Morand

James Harris

Fabien B Vincent

P577

2018-06-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29930551

http://www.w3.org/2001/XMLSchema#string

P932

5999794

http://www.w3.org/2001/XMLSchema#string

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

about

P2860

P2860

Analysis of Serum Interleukin (IL)-1β and IL-18 in Systemic Lupus Erythematosus.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P50

P577

P698

P932